相关实验视频

Updated: Jun 28, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

通过中等宇宙 (mesocosms) 推进水生生态毒理学对抗癌药物的测试

Andrea Carboni^1,2, Matteo Calvaresi^1,2

¹Dipartimento di Chimica "Giacomo Ciamician", Alma Mater Studiorum-Università di Bologna, Via Piero Gobetti, 85, 40129 Bologna, Italy.

Molecules (Basel, Switzerland)

|December 31, 2025

概括

抗癌药物 (ACD) 污染水生环境,对非标生物构成风险. 中宇宙研究提供了一种现实的方法来评估ACDs.

科学领域:

环境化学环境化学
生态毒理学生态毒理学
水生生态学水生生态学

背景情况:

抗癌药物 (ACD) 的广泛使用导致它们在水生生态系统中的存在.
ACDs是强大的细胞毒性化合物,即使在微量度下也具有生物活性,影响非标生物.
传统的毒性测试缺乏生态现实性,忽视了复杂的相互作用和长期暴露.

研究的目的:

突出水生系统中ACD污染对环境的关注.
检查 ACD 传统生态毒理学评估方法的局限性.
倡导进行中宇宙研究,以便全面了解ACD对环境的影响.

主要方法:

对ACD环境命运和毒性当前知识的审查.
讨论传统单种,单端毒性试验的局限性.
强调模拟生态系统实验 (mesocosms) 以实现现实的暴露场景.

主要成果:

废水废水和淡水中无处不在的ACDs,造成生态风险.
传统的测试不足以评估ACD的慢性毒性和复杂的生态系统影响.
中间宇宙为评估长期ACD暴露和影响提供了一个有价值的平台.

结论:

半宇宙研究对于桥梁实验室研究和生态系统层面对ACD的理解至关重要.
整合中宇宙数据可以更好地预测ACD行为和生态后果.
使用中宇宙进行增强的风险评估可以指导用于保护水生生物的缓解策略.

关键词:

水生生态系统的水生生态系统化学疗法药物化学疗法药物生态毒性生态毒性新兴污染物是新出现的污染物.环境影响环境影响环境影响

更多相关视频

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

相关概念视频

Toxicity Testing in Animals

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...